Affiliation:
1. Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Seville, Spain
2. Department of Neuroscience, Faculty of Medicine, University of Cádiz, Spain
Abstract
Abstract
Naltrexone hydrochloride, an opioid antagonist used as an adjunct to the maintenance of the opioid-free state for detoxified individuals, was introduced into the polymeric structure of Eudragit L30D, ananionic copolymer based on polymethacrylic acid and ethylacrylate. From the results of a preclinical study, this complexation technique can be considered as a useful tool in the design of oral controlled-release systems (naltrexone-Eudragit L) capable of inducing long-lasting effects in-vivo. The biopharmaceutical characterization of the naltrexone-Eudragit L complex in comparison with naltrexone hydrochloride using the mouse hot-plate model has been previously carried out. The results showed a longer effect, an enhancement of 23.47% of the area under the curve of the inhibition of analgesic activity vs time, and a delay of 51.80% in the t1/2 value induced by the complex, compared with those induced by conventional naltrexone. In this study, a regimen of chronic administration of naltrexone-Eudragit L was established. Thus, in an 8-day treatment (4 doses in alternate days) this oral controlled-release system effectively antagonized the analgesic effect of morphine for 8 h, whereas naltrexone hydrochloride has to be administered over 16 days (8 doses in alternate days) to induce the same effect. In the 16-day schedule the complex-induced antagonism lasted over 14 h after administration.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference15 articles.
1. Morphine polymeric coprecipitates for controlled release: elaboration and characterization;Álvarez-Fuentes;Drug Dev. Ind. Pharm.,1994
2. Characterization of morphine polymeric coprecipitates. Biopharmaceutical study;Álvarez-Fuentes;Pharmazie,1994
3. Study of a complexation process between naltrexone and Eudragit L as an oral controlled release system;Álvarez-Fuentes;Int. J. Pharm.,1997
4. Estudio preliminar para la valoración de un compuesto antagonista opiáceo de liberación controlada;Álvarez-Fuentes;Industria Farmacéutica,1997
5. Preclinical study of an oral controlled release naltrexone complex;Álvarez-Fuentes;J. Pharm. Pharmacol.,2000
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献